Jeffrey Brindle, MD
Radiation Oncology · Watertown, SDNPI 1619906120
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 7.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,132 and has fallen 95.5% since, to $51 in 2022.
Across 90 payments — averaging $15.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$107
- Johnson & Johnson$106
- Bristol Myers Squibb$101
- Amgen$94
- Novartis$84
- Daiichi Sankyo Inc.$80
- plus $840 from 26 others
What the payments were for
- Food & beverage$1,411100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 5 | $107 |
| Johnson & Johnson | 7 | $106 |
| Bristol Myers Squibb | 7 | $101 |
| Amgen | 6 | $94 |
| Novartis | 5 | $84 |
| Daiichi Sankyo Inc. | 6 | $80 |
| Tesaro, Inc. | 4 | $67 |
| Exelixis Inc. | 3 | $64 |
| Octapharma USA, Inc. | 3 | $59 |
| AstraZeneca(2 entities) | 4 | $57 |
| Progenics Pharmaceuticals, Inc. | 1 | $51 |
| Clovis Oncology, Inc. | 4 | $50 |
| EMD Serono, Inc. | 3 | $40 |
| Dova Pharmaceuticals | 3 | $39 |
| Teva Pharmaceuticals USA, Inc. | 3 | $39 |
| Merck | 2 | $31 |
| Boehringer Ingelheim | 2 | $29 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $28 |
| Varian Medical Systems, Inc. | 1 | $27 |
| Bayer | 2 | $27 |
| Rigel Pharmaceuticals, Inc. | 2 | $24 |
| E.r. Squibb & Sons, L.L.C. | 2 | $23 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $23 |
| Incyte Corporation | 2 | $23 |
| Pfizer | 2 | $23 |
| AbbVie | 1 | $22 |
| Astellas Pharma US Inc | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Sanofi | 1 | $15 |
| Dendreon Pharmaceuticals LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Ipsen Biopharmaceuticals, Inc | 1 | $13 |
How this compares
Too few radiation oncology providers in South Dakotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Watertown
- Joni Buechler PriceWatertown$127
- Daniel PetereitRapid City$6K
- Kathleen SchneeklothSioux Falls$4K
- Kyle ArnesonSioux Falls$2K
- Daniel TackettRapid City$975
- Michael PetersonYankton$519
- Michael SwartzRapid City$413
- Eric EastmoRapid City$368
- Stephen DickMitchell$203
- Ryan NowakSioux Falls$191
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.